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 Introduction 
 The availability of long-chain polyunsaturated fatty 
acids (LCPUFAs) and especially the supply of docosa-
hexaenoic acid (DHA) appears to modify the develop-
ment of visual and cognitive functions during early life 
 [1–5] . The LCPUFA content of the diet influences mem-
brane structure and function, and also effects the pro-
duction of second messengers, such as eicosanoids that 
influence many cell-associated functions  [6] . During ges-
tation and infancy, the supply of preformed LCPUFA can 
influence neural functions  [6] . LCPUFAs accumulate in 
the fetal tissues primarily during the period of rapid 
growth in the last trimester of pregnancy  [7, 8] , a period 
of fetal adipose tissue development  [9] and extensive 
brain growth  [10] . Essential fatty acids cannot be synthe-
sized by humans and must be supplied through placental 
transport to the fetus and with human milk or milk sub-
stitute formulae to the infant. Human milk supplies not 
only the essential fatty acids linoleic and   -linolenic ac-
ids, but also their LCPUFA metabolites  [1, 19] . Lipid con-
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 Abstract 
 Background: Fatty acid composition of human milk serves 
as guidance for the composition of infant formulae. The aim 
of the study was to systematically review data on the fatty 
acid composition of human milk of mothers of preterm com-
pared to full-term infants.  Methods: An electronic literature 
search was performed in English (Medline and Medscape) 
and German (SpringerLink) databases and via the Google 
utility. Fatty acid compositional data for preterm and full-
term human milk were converted to differences between 
means and 95% confidence intervals.  Results: We identified 
five relevant studies publishing direct comparison of fatty 
acid composition of preterm versus full-term human milk. 
There were no significant differences between the values of 
the principal saturated and monounsaturated fatty acids. In 
three independent studies covering three different time 
points of lactation, however, docosahexaenoic acid (DHA) 
values were significantly higher in milk of mothers of pre-
term as compared to those of full-term infants, with an ex-
tent of difference considered nutritionally relevant.  Conclu-
sion: Higher DHA values in preterm than in full-term human 
milk underlines the importance of using own mother’s milk 
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tent and fatty acid composition of human milk is report-
edly influenced by a variety of variables such as genetic 
background of the lactating woman, maternal nutrition-
al status, maternal dietary intakes immediately before 
and during gestation, the number of previously breastfed 
infants and the stage of lactation  [1, 8, 9] . It has also been 
debated whether fatty acid composition of human milk 
differs after preterm as compared to full-term delivery 
 [13–17] . This question is of relevance for determining op-
timal dietary fatty acid intake of pregnant and lactating 
woman as well as LCPUFA contents of formulae for pre-
term infants.
 This paper systematically reviews the published infor-
mation on fatty acid composition of human milk in moth-
ers of preterm as compared to those of full-term infants.
 Methods 
 We performed an electronic literature search in English (Med-
line (www.pubmed.com) and Medscape (www.medscape.com)) 
and German (SpringerLink (www.springerlink.com)) databases 
from their start dates to November 2005 onwards. The searching 
expressions were as follows: human milk or breast milk, com-
bined with essential fatty acid or long-chain polyunsaturated fat-
ty acid or arachidonic acid or docosahexanoic acid. We also 
checked the list of references in the publications identified. We 
attempted to reveal unpublished evidence by consulting abstract 
books of relevant scientific meetings and by contacting experts 
working in this field.
 Fatty acid composition of preterm or full-term human milk 
was reported in several studies, whereas data obtained in direct 
comparison of the fatty acid composition of preterm and full-
term human milk within the same study were published only in 
five reports. Each of these studies was a longitudinal study and 
investigated human milk from apparently healthy mothers who 
had delivered preterm or full-term infants. Both pregnancies and 
deliveries were normal in all these studies. The gestational ages of 
preterm infants were between 25 and 36 weeks, whereas those of 
full-term infants were  1 37 weeks. There was no history of any 
disease of the offspring. All the women in the study of Genzel-
Boroviczény et al.  [15] , Luukkainen et al.  [14] and Kovács et al.  [17] 
were apparently on omnivorous diet. No information was given 
about the dietary background of mothers in the study of Bitman 
et al.  [13] and Rueda et al.  [16] .
 There were some methodological differences in the studies re-
viewed here. The sample collections were at different time points 
of lactation (for details see Results). Storage temperature of the 
milk samples was either –20 or –70 or –80 ° C. For fatty acid anal-
ysis, lipids were extracted either with chloroform-methanol or us-
ing a mixture of benzene-methanol-acetylchloride. Fatty acid 
methyl esters were determined by capillary gas liquid chromatog-
raphy in all studies except the classical study of Bitman et al.  [13] , 
who used packed column gas liquid chromatography being the 
predominant method at the time. Results of the fatty acid compo-
sition were expressed as weight percentages of all fatty acids and 
were presented as means and SD  [16] , means and SE  [13] , median 
and IQR  [15, 17] or means and 95% confidence intervals (CIs)  [14] . 
For a better comparability, we calculated all data into the form of 
means and SD from the published data or the original databases 
of the two studies where medians and interquartile ranges were 
published  [15, 17] . For arachidonic acid (AA) and docosahexa-
noic acid (DHA) values, i.e. the principal LCPUFAs of human 
milk we also calculated the difference of means between preterm 
and full-term milk and the 95% CIs of the difference of means by 
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 where PSD = pooled SD, N 1 = number of subjects in group 1 (in 
our study: preterm), s 1 = standard deviation of group 1, N 2 = num-
ber of subjects in group 2 (in our study: full-term), s 2 = standard 
deviation of group 2; SED = standard error of the difference, X 1 = 
mean of group 1, X 2 = mean of group 2, t * = value of t-distribu-
tion at the given confidence level with degree of freedom = N 1 + 
N 2 – 2. 
 Results 
 Fatty acid compositions of preterm and full-term hu-
man milk investigated in 18 comparisons published in 
five studies are shown in  tables 1–3 .
 Preterm breast milk showed higher contents of the sat-
urated fatty acids myristic acid (C14: 0) at two different 
time points in the study of Kovács et al.  [17] and in the 
study of Genzel-Boroviczény et al.  [15] , palmitic acid 
(C16: 0) values at one time point in the study of Kovács et 
al.  [17] and stearic acid (C18: 0) values at one time point 
in the study of Luukkainen et al.  [14] ( table 1 ). The  cis-
 monounsaturated fatty acid oleic acid (C18: 1n–9) was 
higher in preterm milk at two different time points in the 
study of Kovács et al.  [17] and at three different times in 
the study of Rueda et al.  [16] ( table 1 ). Values of the prin-
cipal n–6 polyunsaturated fatty acids, linoleic acid (C18: 
 2n–6, LA),   -linolenic acid (C18:  3n–6, GLA) and arachi-
donic acid (C20: 4n–6, AA) values were reported in all 
studies, whereas dihomo-  -linolenic acid (C20: 3n–6, 
DHGLA) values were reported only in four studies. Data 
on the principal n–3 polyunsaturated fatty acids, docosa-
pentaenoic acid (C22: 5n–3) and docosahexaenoic acid 
(C22: 6n–3, DHA) were reported in all studies, whereas 
eicosapentaenoic acid (C20: 5n–3, EPA) values were re-
ported only in four and   -linolenic acid (C18: 3n–3, ALA) 
values in three studies.
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 Values of LA, ALA and EPA did not differ between 
preterm and full-term human milk in any of the five 
studies. In contrast, GLA values were significantly high-
er in colostrum of mothers giving birth to preterm in-
fants than in those delivering at term in the study of 
Kovács et al.  [17] . Values of the principal n–3 LCPUFA 
DHA were significantly higher in preterm breast milk 
at 1, 4, 7, 14 and 21 days, and of the n–6 LCPUFA AA at 
all time points except day 14 in the study of Kovács et al. 
 [17] , whereas both fatty acids were found at higher levels 
only at days 28–35 by Luukkainen et al.  [14] ( tables 2 ,  3 ). 
Values of the major intermediary metabolite of the syn-
thesis of AA, DHGLA, were found to be significantly 
higher in milk samples obtained from mothers of pre-
term than in those collected from mothers of full-term 
infants in the study of Kovács et al.  [17] , and values of 
C22: 5n–3 (intermediary metabolite of the synthesis of 
DHA) were significantly higher in preterm breast milk 
in the study of Kovács et al.  [17] at 7 and 21 days, and in 
the study of Luukkainen et al.  [14] at 12 and 26 weeks 
( table 2 ,  3 ).
 The differences of the means and the 95% CIs of the 
difference for DHA and AA values measured in milk 
samples obtained from mothers of preterm and full-term 
infants in the five studies are shown in  figures 1 and  2 , 
respectively. The difference of mean DHA values (pre-
term vs. term) were significantly different from zero in 
three studies  [14, 16, 17] , covering three different time 
points. In the study of Kovács et al.  [17] , AA value differ-
ence were positive at three different time points of lacta-
tion, whereas the data of Rueda et al.  [16] showed negative 
95% CIs for AA values at two different time points of lac-
tation.










preterm full-term preterm full-term preterm full-term preterm full-term
Bitman et al. [13] (USA)
42 (VPT) 18 6 8.41 (3.32) 5.68 (3.31) 20.13 (5.6) 22.2 (5.58) 7.24 (4.52) 7.68 (4.53) 33.41 (6.69) 35.51 (6.69)
42 (PT) 28 6 7.55 (4.71) 5.68 (3.31) 23.16 (7.59) 22.2 (5.58) 7.25 (6.17) 7.68 (4.53) 33.74 (9.13) 35.51 (6.69)
Luukkainen et al. [14] (Finland)
1–7 12 8 7.47 (5.10) 6.64 (4.67) 28.27 (4.70) 29.04 (3.63) 9.8 (1.47) 9.95 (3.16) 39.17 (6.85) 38.92 (6.88)
8–14 11 10 9.88 (6.14) 8.12 (5.12) 27.89 (2.20) 28.39 (5.37) 9.62 (1.35)** 11.38 (2.16) 37.65 (4.45) 38.00 (5.88)
15–21 9 7 7.96 (4.11) 6.36 (6.65) 26.00 (4.36) 27.66 (6.88) 9.48 (2.47) 10.43 (2.55) 38.83 (4.45) 39.71 (7.47)
22–27 16 10 8.77 (3.40) 7.86 (5.77) 26.20 (3.25) 27.53 (5.08) 10.29 (1.61) 10.82 (3.31) 38.47 (2.42) 38.03 (7.33)
28–35 14 5 7.7 (2.57) 8.7 (5.85) 26.12 (4.26) 28.02 (7.35) 10.27 (1.66) 10.00 (7.43) 38.61 (2.64) 36.95 (6.49)
Genzel-Boroviczény et al. [15] (Germany)
5 19 32 7.65 (1.64) 6.93 (2.49) 23.84 (3.16) 24.56 (5.14) 6.66 (0.92) 7.23 (1.10) 33.49 (6.67) 32.16 (4.22)
10 19 38 8.7 (2.26)* 7.07 (2.5) 22.74 (3.02) 22.29 (6.25) 7.61 (1.48) 7.60 (1.22) 29.73 (9.58) 31.59 (4.26)
20 17 38 9.15 (2.73)* 7.29 (1.81) 22.42 (1.88) 23.16 (3.07) 8.03 (1.50) 7.69 (1.21) 31.18 (3.95) 31.74 (3.04)
30 13 38 8.98 (3.08) 7.39 (2.51) 22.74 (2.64) 22.76 (1.62) 7.73 (1.22) 7.47 (1.22) 31.52 (4.28) 30.74 (5.81)
Rueda et al. [16] (Spain)
1–5 6 16 6.70 (2.17) 6.60 (1.79) 21.05 (0.79) 20.81 (2.19) 5.69 (0.53) 7.36 (4.13) 30.70 (3.49)* 34.93 (2.67)
6–15 6 16 7.57 (2.04) 8.21 (2.25) 19.56 (2.19) 19.59 (2.19) 6.09 (1.05) 6.28 (1.01) 39.86 (5.47)** 33.61 (3.26)
16–35 6 16 6.27 (1.60) 6.42 (3.00) 19.03 (4.68) 18.85 (2.57) 6.50 (1.97) 6.70 (0.89) 38.14 (5.25)* 47.37 (6.42)
Kovács et al. [17] (Hungary)
1 8 10 6.18 (2.25) 5.19 (1.51) 24.21 (3.05)* 27.78 (2.21) 4.99 (1.17) 5.33 (0.99) 35.82 (4.42) 35.73 (3.18)
4 8 10 9.36 (5.13) 6.10 (1.66) 23.97 (2.46) 25.47 (2.72) 4.97 (0.85) 5.29 (1.33) 33.24 (5.47) 36.02 (2.14)
7 8 10 9.68 (4.64)** 5.69 (1.63) 23.02 (2.46) 25.16 (3.25) 5.35 (1.01) 5.44 (1.07) 32.3 (4.25) 36.37 (2.8)
14 8 10 9.87 (4.59)* 5.55 (1.82) 22.83 (3.38) 23.49 (1.69) 5.42 (0.43) 5.32 (0.93) 32.38 (3.92)** 35.94 (2.54)
21 8 10 8.36 (2.69) 5.68 (2.34) 22.41 (4.87) 23.78 (3.38) 5.41 (0.57) 5.78 (1.45) 31.21 (2.84)* 36.01 (4.24)
VPT = Very preterm, PT = preterm.
Data are in weight percent presented as means (SD). * p < 0.05, ** p < 0.001.
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Table 2. Major n–3 polyunsaturated fatty acids in preterm and full-term human milk
Day of
lactation
C18:3n–3 C20:5n–3 C22:5n–3 C22:6n–3 (DHA)
preterm full-term preterm full-term preterm full-term preterm full-term
Bitman et al. [13]
42 (VPT) 0.76 (0.52) 1.03 (0.51) 0.55 (0.72) n.d. 0.42 (0.36) 0.11 (0.36) 0.24 (0.36) 0.23 (0.34)
42 (PT) 0.76 (0.71) 1.03 (0.51) n.d. n.d. 0.12 (0.51) 0.11 (0.36) 0.21 (0.46) 0.23 (0.34)
Luukkainen et al. [14]
1–7 0.85 (0.34) 1.01 (0.27) 0.1 (0.05) 0.08 (0.04) 0.32 (0.78) 0.24 (0.49) 0.54 (1.32) 0.44 (0.89)
8–14 1.01 (0.66) 1.06 (0.67) 0.09 (0.15) 0.08 (0.08) 0.22 (0.54) 0.16 (0.33) 0.42 (1.03) 0.38 (0.77)
15–21 1.33 (1.05) 1.22 (0.78) 0.08 (0.07) 0.09 (0.08) 0.19 (0.46) 0.24 (0.49) 0.3 (0.73) 0.3 (0.61)
22–27 1.21 (0.49) 1.3 (0.49) 0.11 (0.09) 0.1 (0.08) 0.21 (0.51)** 0.1 (0.20) 0.35 (0.86) 0.18 (0.37)
28–35 1.24 (0.44) 1.45 (1.16) 0.09 (0.02) 0.07 (0.1) 0.22 (0.53)** 0.08 (0.16) 0.39 (0.95)** 0.18 (0.37)
Genzel-Boroviczény et al. [15]
5 0.73 (0.49) 0.66 (0.19) 0.04 (0.06) 0.11 (0.21) 0.23 (0.05) 0.22 (0.08) 0.45 (0.11) 0.45 (0.11)
10 0.74 (0.26) 0.84 (0.27) 0.04 (0.06) 0.03 (0.08) 0.17 (0.04) 0.17 (0.05) 0.37 (0.14) 0.39 (0.09)
20 0.78 (0.21) 0.82 (0.27) 0.08 (0.15) 0.06 (0.09) 0.17 (0.11) 0.17 (0.05) 0.29 (0.26) 0.30 (0.13)
30 0.96 (0.38) 0.74 (0.17) 0.05 (0.07) 0.12 (0.18) 0.15 (0.06) 0.17 (0.08) 0.25 (0.05) 0.32 (0.25)
Rueda et al. [16] 
1–5 n.d. n.d. 0.15 (0.04) 0.20 (0.19) 0.42 (0.2) 0.4 (0.2) 0.48 (0.11) 0.86 (0.96)
6–15 n.d. n.d. 0.19 (0.01) 0.10 (0.05) 0.31 (0.07) 0.26 (0.29) 0.48 (0.2) 0.41 (0.12)
16–35 n.d. n.d. n.d. 0.07 (0.03) n.d. 0.17 (0.04) 0.69 (0.42) 0.33 (0.12)
Kovács et al. [17]  
1 0.42 (0.27) 0.28 (0.14) n.d. n.d. 0.19 (0.11) 0.10 (0.09) 0.32 (0.12)* 0.25 (0.14)
4 0.39 (0.20) 0.34 (0.23) n.d. n.d. 0.14 (0.05) 0.08 (0.07) 0.30 (0.13)* 0.20 (0.11)
7 0.49 (0.21) 0.41 (0.25) n.d. n.d. 0.12 (0.05)* 0.06 (0.05) 0.32 (0.13)** 0.16 (0.09)
14 0.49 (0.25) 0.43 (0.19) n.d. n.d. 0.11 (0.06) 0.05 (0.03) 0.24 (0.12)* 0.15 (0.09)
21 0.46 (0.20) 0.39 (0.14) n.d. n.d. 0.12 (0.07)* 0.05 (0.03) 0.19 (0.07)* 0.13 (0.07)
VPT = Very preterm, PT = preterm; n.d. = not determined.
Data are in weight percent presented as means (SD). * p < 0.05, ** p < 0.001.
–1.0 –0.8 –0.6 –0.4 –0.2 0 0.2 0.4 0.6 0.8 1.0
 Fig. 1. The differences of the means and 
the 95% CIs of the difference for arachi-
donic acid values measured in milk sam-
ples obtained from mothers of preterm 
and full-term infants in five studies. Each 
horizontal line represents one statistical 
comparison. The middle symbol on the 
horizontal line depicts mean value, where-
as the lateral symbols show 95% CIs.  j = 
Bitman et al.  [13] : preterm (upper line) and 
very preterm (lower line) at day 42;  ) = 
Luukkainen et al.  [14] : at days: 1–7, 8–14, 
15–21, 22–27, 28–35 (top down);  d = Gen-
zel-Boroviczény et al.  [15] : at days: 5, 10, 20 
and 30 (top down);  X = Rueda et al.  [16] : at 
days: 1–5, 6–15 and 16–35 (top down);  $ = 
Kovács et al.  [17] : at days: 1, 4, 7, 14 and 21 
(top down). 
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Table 3. Major n–6 polyunsaturated fatty acids in preterm and full-term human milk
Day of
lactation
C18:2n–6 C18:3n–6 C20:3n–6 (DHGLA) C20:4n–6 (AA)
preterm full-term preterm full-term preterm full-term preterm full-term
Bitman et al. [13]
42 (VPT) 15.75 (4.88) 15.58 (4.87) n.d. n.d. 0.51 (0.52) 0.53 (0.51) 0.55 (0.72) 0.6 (0.71)
42 (PT) 13.83 (6.63) 15.58 (4.87) n.d. n.d. 0.43 (0.51) 0.53 (0.51) 0.58 (0.97) 0.6 (0.71)
Luukkainen et al. [14]
1–7 8.8 (3.08) 9.92 (3.69) 0.48 (1.17) 0.43 (0.88) n.d. n.d. 0.59 (1.44) 0.6 (1.22)
8–14 8.79 (2.72) 8.69 (3.96) 0.34 (0.83) 0.33 (0.67) n.d. n.d. 0.47 (1.15) 0.44 (0.89)
15–21 11.75 (7.32) 9.85 (5.75) 0.31 (0.76) 0.37 (0.75) n.d. n.d. 0.39 (0.95) 0.49 (1.0)
22–27 10.32 (3.91) 10.46 (2.38) 0.28 (0.68) 0.28 (0.57) n.d. n.d. 0.36 (0.88) 0.33 (0.67)
28–35 11.32 (3.69) 11.52 (8.71) 0.27 (0.66) 0.18 (0.37) n.d. n.d. 0.37 (0.91)* 0.28 (0.57)
Genzel-Boroviczény et al. [15]  
5 9.86 (2.17) 9.81 (3.26) 0.31 (0.64) 0.11 (0.08) 0.59 (0.29) 0.55 (0.23) 0.72 (0.12) 0.76 (0.14)
10 10.34 (2.79) 10.99 (3.51) 0.11 (0.08) 0.18 (0.12) 0.46 (0.12) 0.45 (0.19) 0.62 (0.11) 0.60 (0.14)
20 9.89 (2.18) 11.11 (4.13) 0.15 (0.11) 0.32 (0.57) 0.40 (0.12) 0.39 (0.09) 0.50 (0.05) 0.50 (0.09)
30 10.46 (2.36) 11.81 (3.44) 0.16 (0.05) 0.29 (0.46) 0.40 (0.12) 0.41 (0.15) 0.48 (0.05) 0.46 (0.05)
Rueda et al. [16] 
1–5 12.59 (2.7) 12.42 (1.83) 0.14 (0.06) 0.22 (0.2) 0.73 (0.15) 0.69 (0.25) 0.91 (0.29) 0.83 (0.3)
6–15 13.07 (2.75) 14.22 (3.66) 0.18 (0.04) 0.09 (0.04) 0.55 (0.07) 0.62 (0.2) 0.71 (0.12) 0.85 (0.17)
16–35 10.75 (2.03) 14.3 (4.02) 0.18 (0.03) 0.06 (0.01) 0.4 (0.04) 0.47 (0.09) 0.46 (0.04) 0.66 (0.14)
Kovács et al. [17] 
1 14.58 (3.81) 16.30 (2.56) 0.12 (0.09)* 0.03 (0.01) 0.63 (0.16) 0.51 (0.24) 0.91 (0.23)* 0.75 (0.33)
4 13.89 (3.24) 16.81 (3.12) 0.06 (0.03) 0.05 (0.06) 0.56 (0.15)** 0.34 (0.12) 0.76 (0.22)* 0.52 (0.19)
7 14.22 (3.77) 17.76 (5.82) 0.08 (0.03) 0.09 (0.13) 0.54 (0.18)** 0.28 (0.13) 0.75 (0.21)** 0.42 (0.16)
14 14.72 (4.50) 19.49 (5.15) 0.08 (0.03) 0.05 (0.04) 0.46 (0.15)* 0.27 (0.08) 0.57 (0.20) 0.43 (0.16)
21 18.83 (5.77) 18.65 (7.44) 0.07 (0.02) 0.11 (0.09) 0.47 (0.19)* 0.25 (0.08) 0.59 (0.22)* 0.35 (0.13)
VPT = Very preterm, PT = preterm; n.d. = not determined.
Data are in weight percent presented as means (SD). * p < 0.05, ** p < 0.001.
–1.2 –1.0 –0.8 –0.6 –0.4 –0.2 0 0.2 0.4 0.6 0.8
 Fig. 2. The differences of the means and 
the 95% CIs of the difference for docosa-
hexaenoic acid values measured in milk 
samples obtained from mothers of pre-
term and full-term infants in five studies. 
For further details of the legend, see fig-
ure 1. 
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 Discussion 
 Breast milk, which provides considerable amounts of 
LCPUFAs, is considered to provide the optimal form of 
nutrition for young infants  [8, 12, 18, 19] . During gesta-
tion, significant amounts of DHA and other LCPUFAs 
are transferred to the developing fetus for optimal growth 
and development by an active and selective transport  [20, 
21] . The tissue values of AA and DHA increase steadily 
with increasing gestational age  [9] ; LCPUFAs accumulate 
in the fetus, especially during the last trimester of preg-
nancy  [1, 7, 8] . The availability of LCPUFAs for the devel-
opment of newborn infants depends on LCPUFA stores 
at birth, on LCPUFA supply by way of nutrition, and on 
the ability of the infant to synthesize LCPUFAs from 
their shorter-chain precursors  [22] . Due to the lack of 
substrate accumulation during late gestation, low-birth-
weight preterm infants have only very limited body stores 
of PUFAs and LCPUFAs at birth, whereas the require-
ments for deposition in their rapidly growing tissues are 
high  [23, 24] . The rate of synthesis may be insufficient to 
allow normal or optimal LCPUFA accretion in body tis-
sues  [17] . Hence, an appropriate supply of preformed di-
etary LCPUFAs is of crucial importance for the optimal 
development in infancy.
 The lipid composition of breast milk can be influenced 
by several factors, such as the mother’s diet and nutri-
tional status during pregnancy and lactation  [25] , post-
partum age, diurnal rhythm, differences between breasts 
 [26] , maternal diseases affecting lipid metabolism  [27] as 
well as various other factors  [11] . The question whether 
the fatty acid composition of human milk also depends 
on gestational age of the infant has been debated for many 
years.
 In the present review, we identified three independent 
studies  [14, 16, 17] covering three different time points of 
lactation where the 95% CIs of the significant difference 
of mean DHA values (preterm minus full-term) were en-
tirely in the positive range, i.e. the percentage contribu-
tion of DHA is higher in preterm than full-term milk. In 
contrast, data for AA were rather controversial: in the 
study of Kovács et al.  [17] the 95% CIs for AA values were 
entirely in the positive range at three different time points 
of lactation, whereas in the study of Rueda et al.  [16] the 
95% CIs for AA values were entirely in the negative range 
at two different time points of lactation, i.e. both signifi-
cantly higher and lower AA levels were reported in pre-
term compared to full-term human milk.
 The LCPUFA content of human milk is closely related 
to maternal LCPUFA body stores  [28–30] . Mothers of 
premature infants transfer less LCPUFAs to the fetus 
during a shorter pregnancy, and also the volume of hu-
man milk consumed by their infants tends to be much 
smaller particularly during the first weeks after birth 
 [15] , which would lead to higher maternal LCPUFA stores 
and thus may explain higher LCPUFA values in preterm 
than in full-term human milk  [17] . Due to the shorter 
period and lesser extent of intrauterine LCPUFA accu-
mulation, preterm infants should have higher postnatal 
LCPUFA requirements than full-term infants. It is tempt-
ing to speculate whether there may be other adaptive or 
regulative mechanism to indicate higher LCPUFA con-
tents in preterm milk in response to higher physiological 
needs of preterm infants, but the occurrence of a signifi-
cant survival rate of small preterm infants is a very new 
phenomenon relative to the time scale of human evolu-
tion and hence it appears unlikely that such mechanisms 
specific to preterm birth would have developed.
 Nonetheless, higher DHA values in preterm than in 
full-term human milk indicate a likely benefit of utilizing 
own mother’s milk for feeding preterm infants. More-
over, these data should lead to a reconsideration of the 
DHA levels in formulae for preterm infants, which cur-
rently tend to mimic DHA levels of full-term human milk 
and thus tend to differ from the fatty acid composition of 
human milk of mothers giving birth to preterm infants.
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